0001822931-23-000004.txt : 20230524 0001822931-23-000004.hdr.sgml : 20230524 20230524122429 ACCESSION NUMBER: 0001822931-23-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20230524 DATE AS OF CHANGE: 20230524 EFFECTIVENESS DATE: 20230524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Emerging Markets Healthcare Partners International Ltd. CENTRAL INDEX KEY: 0001822931 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-374631 FILM NUMBER: 23952833 BUSINESS ADDRESS: STREET 1: C/O OGIER GLOBAL (CAYMAN) LIMITED STREET 2: 89 NEXUS WAY CITY: CAMANA BAY, GRAND CAYMAN STATE: E9 ZIP: KY1-9009 BUSINESS PHONE: (345) 949-9876 MAIL ADDRESS: STREET 1: C/O OGIER GLOBAL (CAYMAN) LIMITED STREET 2: 89 NEXUS WAY CITY: CAMANA BAY, GRAND CAYMAN STATE: E9 ZIP: KY1-9009 D/A 1 primary_doc.xml X0708 D/A LIVE 0001822931 Emerging Markets Healthcare Partners International Ltd. C/O OGIER GLOBAL (CAYMAN) LIMITED 89 NEXUS WAY CAMANA BAY, GRAND CAYMAN E9 CAYMAN ISLANDS KY1-9009 (345) 949-9876 CAYMAN ISLANDS None None Other Cayman Islands Exempted Company true 2020 Samuel D. Isaly Exome Asset Management LLC 330 Madison Avenue, Suite 3010 New York NY NEW YORK 10017 Director Promoter Carlos Manuel Godoy Exome Asset Management LLC 330 Madison Avenue, Suite 3010 New York NY NEW YORK 10017 Director Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 true 0001822931-23-000002 2020-09-01 true true true false 1000000 Fairview Securities, Inc. 35703 Fairview Securities, Inc. 35703 154 Long Lots Road Westport CT CONNECTICUT 06880 TX TEXAS FL FLORIDA false Indefinite 3093966 Indefinite false 14 1064 0 0 Customary advisory fees will be paid to the Investment Manager at the master fund level as provided for in the Issuer's offering materials. false Emerging Markets Healthcare Partners International Ltd. Samuel D. Isaly Samuel D. Isaly Director 2023-05-24